<div class="container">

<table style="width: 100%;"><tr>
<td>betablocker</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Clinical Trial of Beta-Blockers</h2>

<h3>Description</h3>

<p>22-centre clinical trial of beta-blockers for reducing mortality after
myocardial infarction.
</p>


<h3>Usage</h3>

<pre><code class="language-R">data("betablocker")</code></pre>


<h3>Format</h3>

<p>A data frame with 44 observations on the following 4 variables.
</p>

<dl>
<dt>Deaths</dt>
<dd>
<p>Number of deaths.</p>
</dd>
<dt>Total</dt>
<dd>
<p>Total number of patients.</p>
</dd>
<dt>Center</dt>
<dd>
<p>Number of clinical centre.</p>
</dd>
<dt>Treatment</dt>
<dd>
<p>A factor with levels <code>Control</code> and <code>Treated</code>.</p>
</dd>
</dl>
<h3>Source</h3>

<p>G. McLachlan and D. Peel. <em>Finite Mixture Models</em>, 2000.
John Wiley and Sons Inc.
<a href="http://www.maths.uq.edu.au/~gjm/DATA/mmdata.html">http://www.maths.uq.edu.au/~gjm/DATA/mmdata.html</a>
</p>


<h3>References</h3>

<p>M. Aitkin. Meta-analysis by random effect modelling in
generalized linear models.
<em>Statistics in Medicine</em>, <b>18</b>, 2343–2351, 1999.
</p>
<p>S. Yusuf, R. Peto, J. Lewis, R. Collins and P. Sleight. Beta
blockade during and after myocardial infarction: an overview of the
randomized trials.
<em>Progress in Cardiovascular Diseases</em>, <b>27</b>, 335–371,
1985. 
</p>


<h3>Examples</h3>

<pre><code class="language-R">data("betablocker", package = "flexmix")
betaMix &lt;- initFlexmix(cbind(Deaths, Total - Deaths) ~ 1 | Center,
                       data = betablocker, k = 3, nrep = 5,
                       model = FLXMRglmfix(family = "binomial",
                         fixed = ~Treatment)) 
</code></pre>


</div>